DAL-VESSEL - A RANDOMISED, PLACEBO-CONTROLLED STUDY OF DALCETRAPIB ON ENDOTHELIAL FUNCTION, AS MEASURED BY FLOW MEDIATED DILATATION, IN HIGH-RISK PATIENTS